Antibiotic (mis)use needs proper regulation
India consumes a high volume of broad-spectrum antibiotics - drugs that treat a wide range of common bacterial infections and should be used sparingly - and unapproved formulations of medicines. This high volume of antibiotic consumption is mainly...

World Bank data shows AMR could result in $1 trillion in additional healthcare costs by 2050, and $1-3.4 trillion in GDP losses annually by 2030. AMR affects countries in all regions and at all income levels. Its drivers and consequences are exacerbated by poverty and inequality. Low- and middle-income countries like India are worst affected. Globally, India tops the list with the highest antibiotic consumption and highest AMR. There are good reasons for this. India consumes a high volume of broad-spectrum antibiotics - drugs that treat a wide range of common bacterial infections and should be used sparingly - and unapproved formulations of medicines. This high volume of antibiotic consumption is mainly due to unrestricted drug manufacturing, marketing and sales, thanks to a weak regulatory structure. Doctors prefer to prescribe drugs, sometimes indiscriminately, rather than order tests.
Doctors warn that AMR resistance to antibiotics has the potential to be a pandemic. To avoid this, one which can have strong socioeconomic effects like Covid, it is imperative to strengthen regulations, invest in healthcare structure and in R&D to leverage new-age tools like AI. This is something the Global Partnership on AI member countries that includes India is doing.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.